These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32501643)
21. The significance of apolipoprotein E structure to the metabolism of plasma triglyceride-rich lipoproteins. Dergunov AD; Rosseneu M Biol Chem Hoppe Seyler; 1994 Aug; 375(8):485-95. PubMed ID: 7811390 [TBL] [Abstract][Full Text] [Related]
22. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells. Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of microRNA-876 Induces Endothelial Cell Apoptosis by Suppressing Bcl-Xl in Development of Atherosclerosis. Xu K; Liu P; Zhao Y Cell Physiol Biochem; 2017; 42(4):1540-1549. PubMed ID: 28723693 [TBL] [Abstract][Full Text] [Related]
24. The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity. Pham T; Kodvawala A; Hui DY Biochemistry; 2005 May; 44(20):7577-82. PubMed ID: 15896001 [TBL] [Abstract][Full Text] [Related]
25. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Chen M; Masaki T; Sawamura T Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130 [TBL] [Abstract][Full Text] [Related]
26. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice. Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802 [TBL] [Abstract][Full Text] [Related]
27. Electronegative low-density lipoprotein of patients with metabolic syndrome induces pathogenesis of aorta through disruption of the stimulated by retinoic acid 6 cascade. Chen CH; Ke LY; Chan HC; Chu CS; Lee AS; Lin KD; Lee MY; Hsiao PJ; Chen CH; Shin SJ J Diabetes Investig; 2020 May; 11(3):535-544. PubMed ID: 31597015 [TBL] [Abstract][Full Text] [Related]
28. [THE BECOMING IN PHYLOGENESIS OF TRANSFER IN INTERCELLULAR MEDIUM AND ACTIVE ABSORPTION OF POLYENOIC FATTY ACIDS BY CELLS SEQUENTIALLY OF HIGH DENSITY LIPOPROTEINS, LOW DENSITY LIPOPROTEINS AND HIGH DENSITY APOE-LIPOPROTEINS]. Titov VN Klin Lab Diagn; 2015 Jun; 60(6):4-14. PubMed ID: 26466444 [TBL] [Abstract][Full Text] [Related]
29. Structural characterization of a low density lipoprotein receptor-active apolipoprotein E peptide, ApoE3-(126-183). Raussens V; Mah MK; Kay CM; Sykes BD; Ryan RO J Biol Chem; 2000 Dec; 275(49):38329-36. PubMed ID: 10986285 [TBL] [Abstract][Full Text] [Related]
30. Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease. Akyol O; Yang CY; Woodside DG; Chiang HH; Chen CH; Gotto AM Curr Atheroscler Rep; 2024 Jul; 26(7):317-329. PubMed ID: 38753254 [TBL] [Abstract][Full Text] [Related]
31. Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation. Shen MY; Chen FY; Hsu JF; Fu RH; Chang CM; Chang CT; Liu CH; Wu JR; Lee AS; Chan HC; Sheu JR; Lin SZ; Shyu WC; Sawamura T; Chang KC; Hsu CY; Chen CH Blood; 2016 Mar; 127(10):1336-45. PubMed ID: 26679863 [TBL] [Abstract][Full Text] [Related]
32. Membrane surface charge modulates lipoprotein complex forming capability of peptides derived from the C-terminal domain of apolipoprotein E. Pande AH; Tripathy RK; Nankar SA Biochim Biophys Acta; 2009 Jun; 1788(6):1366-76. PubMed ID: 19361484 [TBL] [Abstract][Full Text] [Related]
33. Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies. Chen DY; Sawamura T; Dixon RAF; Sánchez-Quesada JL; Chen CH J Clin Med; 2021 May; 10(9):. PubMed ID: 34066436 [TBL] [Abstract][Full Text] [Related]
35. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784 [TBL] [Abstract][Full Text] [Related]
36. Electronegative L5-LDL induces the production of G-CSF and GM-CSF in human macrophages through LOX-1 involving NF-κB and ERK2 activation. Yang TC; Chang PY; Kuo TL; Lu SC Atherosclerosis; 2017 Dec; 267():1-9. PubMed ID: 29078142 [TBL] [Abstract][Full Text] [Related]
37. SPECT/CT imaging for tracking subendothelial retention of electronegative low-density lipoprotein in vivo. Law SH; Ke CC; Chu CS; Liu SH; Weng MC; Ke LY; Chan HC Int J Biol Macromol; 2023 Oct; 250():126069. PubMed ID: 37536403 [TBL] [Abstract][Full Text] [Related]
38. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways. Qin M; Luo Y; Meng XB; Wang M; Wang HW; Song SY; Ye JX; Pan RL; Yao F; Wu P; Sun GB; Sun XB Vascul Pharmacol; 2015 Jul; 70():23-34. PubMed ID: 25849952 [TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of two monoclonal antibodies specific for the LDL receptor-binding site of human apolipoprotein E. Raffai R; Maurice R; Weisgraber K; Innerarity T; Wang X; MacKenzie R; Hirama T; Watson D; Rassart E; Milne R J Lipid Res; 1995 Sep; 36(9):1905-18. PubMed ID: 8558079 [TBL] [Abstract][Full Text] [Related]
40. Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress. Fang Y; Li J; Ding M; Xu X; Zhang J; Jiao P; Han P; Wang J; Yao S Exp Biol Med (Maywood); 2014 Dec; 239(12):1678-87. PubMed ID: 24962173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]